US: Peter Thiel is leading the search for Trump Administration Antitrust Officials
Buzzfeed news is reporting that billionaire venture capitalist Pete Thiel will be heading up the Trump administration’s search for the nation’s two top antitrust enforcement jobs, according to two unnamed sources.
Thiel is vetting candidates for chairperson of the Federal Trade Commission and antitrust chief at the Department of Justice. Currently Maureen Ohlhausen, a Republican FTC commission member, has been appointed acting chairwoman by the president, but the search for a permanent chairperson is ongoing.
Google favorite Joshua Wright, a former commissioner at the agency, is seen as Google’s favorite for the job — though early reports indicate that he is already out of the running. Sean Reyes, the Utah attorney general, is considered a leading contender – which is less good news for Google, since Reyes last year co-wrote a letter to the FTC asking the agency to consider reopening an antitrust case against Google that it has previously been closed.
Thiel’s challenge, according to the sources, is finding Republicans who are not as libertarian and who are willing to take a Trump-like approach to anti-trust. Though President Trump has no officially released position on the matter, during the campaign he described an active antitrust enforcement regime. Libertarians generally perceive that companies should be left alone — making a potentially robust antitrust position out of President Trump a bit difficult to navigate.
Plus, Thiel has been known to praise monopolies when he believes that dominant market power can give companies the ability to both invest and innovate more.
“Only one thing can allow a business to transcend the daily brute struggle for survival: monopoly profits,” he wrote in his book Zero to One.
Full Content: PYMNTS
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas